Moderna Quarterly Balance Sheet
NASDAQ: MRNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 224.66 -0.15%
Moderna financial position
As of Jun 30, 2026, Moderna reported total assets of $10.96 billion, down 8.7% from a year earlier against total liabilities of $4.20 billion. Shareholders' equity stood at $6.76 billion, or 61.7% of assets. The company held $1.72 billion in cash and equivalents against $591.0 million of debt, a net cash position of $1.13 billion.
The current ratio (current assets divided by current liabilities) was 2.29, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.09.
Summary generated from market data by MetaCap's automated system. Methodology
Moderna balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.72B | 1.91B | 2.60B | 1.13B | 1.28B | 1.62B | 1.93B | 1.64B | 2.48B | 2.05B | 2.91B | 2.93B |
| Short-Term Investments | 3.42B | 3.30B | 3.20B | 3.37B | 3.85B | 4.35B | 5.10B | 5.22B | 6.01B | 6.47B | 5.70B | 4.64B |
| Receivables | 17.00M | 71.00M | 184.00M | 1.05B | 36.00M | 78.00M | 358.00M | 1.56B | 163.00M | 137.00M | 892.00M | 1.87B |
| Inventory | 280.00M | 146.00M | 153.00M | 332.00M | 240.00M | 128.00M | 117.00M | 412.00M | 399.00M | 295.00M | 202.00M | 487.00M |
| Total Current Assets | 5.82B | 5.77B | 6.54B | 6.60B | 6.17B | 6.77B | 8.10B | 9.67B | 9.66B | 9.60B | 10.32B | 10.80B |
| Property, Plant & Equipment | 2.06B | 2.09B | 2.13B | 2.13B | 2.17B | 2.21B | 2.20B | 2.38B | 2.20B | 2.06B | 1.95B | 1.95B |
| Goodwill | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M | 52.00M |
| Intangible Assets | 109.00M | 116.00M | 45.00M | 47.00M | 48.00M | 49.00M | 40.00M | 41.00M | 42.00M | 43.00M | 44.00M | 45.00M |
| Long-Term Investments | 1.77B | 2.25B | 2.34B | 2.14B | 2.37B | 2.42B | 2.49B | 2.33B | 2.33B | 3.64B | 4.68B | 5.27B |
| Total Assets | 10.96B | 11.49B | 12.34B | 12.13B | 12.01B | 12.70B | 14.14B | 15.80B | 15.68B | 16.73B | 18.43B | 19.45B |
| Accounts Payable | 167.00M | 161.00M | 317.00M | 267.00M | 175.00M | 226.00M | 405.00M | 373.00M | 279.00M | 183.00M | 520.00M | 494.00M |
| Total Current Liabilities | 2.53B | 2.40B | 1.99B | 1.68B | 1.57B | 1.60B | 2.21B | 2.20B | 2.36B | 2.38B | 3.02B | 4.38B |
| Long-Term Debt | 591.00M | 590.00M | 590.00M | — | — | — | 0 | — | — | — | — | — |
| Total Liabilities | 4.20B | 4.08B | 3.69B | 2.81B | 2.61B | 2.64B | 3.24B | 3.88B | 3.97B | 3.91B | 4.57B | 6.00B |
| Shareholders' Equity | 6.76B | 7.41B | 8.65B | 9.33B | 9.40B | 10.07B | 10.90B | 11.93B | 11.71B | 12.82B | 13.85B | 13.46B |
| Retained Earnings | 5.10B | 5.88B | 7.22B | 8.05B | 8.25B | 9.07B | 10.04B | 11.16B | 11.15B | 12.43B | 13.61B | 13.39B |
| Total Debt | 591.00M | 590.00M | 590.00M | — | — | — | 0 | — | — | — | — | — |
| Net Cash (Debt) | 4.55B | 4.62B | 5.21B | 4.50B | 5.13B | 5.97B | 7.03B | 6.87B | 8.49B | 8.52B | 8.60B | 7.57B |
| Shares Outstanding | 399.00M | 397.00M | 394.00M | 391.00M | 389.00M | 387.00M | 386.00M | 385.00M | 384.00M | 383.00M | 382.00M | 381.00M |
This table shows 12 quarterly periods of Moderna's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MRNA's reporting calendar. What is a balance sheet?